amongst best corporate governance on asx, page-17

Thanks boiler, loads of info out there on PRR for those that choose to research.
Plenty of chat of pros and cons which is healthy in any stock.
Many of us have chosen to invest in PRR and hold with a view to them continung their trials and developing a much needed treatment for ovarian cancer. A slow process indeed and they have already ticked a few boxes in the area of progression of trials and funding for same with respected experts helping each process. If they ultimately are successful it will be a great thing for medicine and sufferers and ofcourse shareholders.
Investing in bio stocks is high risk, some of us are happy to take that onboard. For those that are not suited to high risk stock best to move on.
I imagine there were plenty of DNDN knockers about before it shot up. PRR may or may not achieve such success, I'll be holding my stock for the ride.